Overview

Non Invasive Assessment of Heart Failure

Status:
Not yet recruiting
Trial end date:
2022-05-01
Target enrollment:
Participant gender:
Summary
1. To Identify the role of aldosterone antagonist in patients of heart failure with preserved ejection fraction. 2. Portray the health profile of heart failure patients admitted in internal medicine department either heart failure with reduced ejection fraction or heart failure with preserved ejection fraction. 3. To compare between patients of right and left sided heart failure by biomarkers and parameters of echocardiographgy 4. Vitamin D and its relation to cardiovascular disease and heart failure.
Phase:
Early Phase 1
Details
Lead Sponsor:
Assiut University
Treatments:
Mineralocorticoid Receptor Antagonists